Cushing's Syndrome Terminated Phase 2 Trials for Nevanimibe (DB16254)
Also known as: Cushing Syndrome / Cushing’s syndrome / Cushings syndrome / Syndrome Cushing's
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028130 (Cushing's Syndrome) | Terminated | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03053271 | A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome | Treatment |